26670 The contribution of itch and skin severity improvements to the Dermatology Life Quality Index in patients with atopic dermatitis in a baricitinib phase 3 study, BREEZE-AD5
2021 ◽
Vol 85
(3)
◽
pp. AB23
Keyword(s):
Phase 3
◽
Keyword(s):
2012 ◽
Vol 132
(1)
◽
pp. 76-84
◽
Keyword(s):
2012 ◽
Vol 87
(5)
◽
pp. 717-723
◽
Keyword(s):
2012 ◽
Vol 52
(1)
◽
pp. 96-101
◽
Keyword(s):
2019 ◽
Vol 139
(10)
◽
pp. 2090-2097.e3
◽
Keyword(s):